Avoparcin

Error creating thumbnail:

avoparcins

Avoparcin is a glycopeptide antibiotic similar in structure and mechanism of action to vancomycin, which was used in agriculture as a growth promoter for livestock. Its use was widespread in many countries to improve the feed efficiency and promote the growth of pigs, poultry, and cattle by altering the gut flora. However, concerns over its contribution to the development of antibiotic-resistant bacteria led to its ban in the European Union (EU) in 1997, with other countries following suit.

Use in Agriculture

Avoparcin was used in low doses in animal feed to promote growth by selectively inhibiting certain bacteria in the gut, which is thought to improve nutrient absorption and feed conversion efficiency. This practice was particularly common in intensive farming operations where maximizing growth rates and feed efficiency is critical for economic viability.

Concerns and Ban

The primary concern leading to the ban of avoparcin was its role in promoting the emergence of antibiotic resistance, particularly vancomycin-resistant Enterococci (VRE). Since vancomycin is a last-resort antibiotic for treating some serious bacterial infections in humans, the spread of VRE was seen as a significant public health threat. Studies indicated that the use of avoparcin in animals could contribute to the reservoir of resistance genes capable of being transferred to human pathogens.

Following the precautionary principle, the EU decided to ban the use of avoparcin as a growth promoter in 1997. This decision was part of a broader move to phase out the use of antibiotics for growth promotion in livestock within the EU, aiming to curb the spread of antibiotic resistance.

Impact of the Ban

The ban on avoparcin, along with other antibiotics used for growth promotion, led to significant changes in livestock management practices within the EU and countries that followed suit. It prompted the development of alternative strategies for disease control and growth promotion in livestock, including improved hygiene measures, vaccination, and the use of probiotics and prebiotics.

Current Status

As of the last update, avoparcin is not approved for use as a growth promoter in the EU and many other jurisdictions. The focus has shifted towards finding sustainable and safe alternatives to antibiotics for growth promotion in livestock, with an emphasis on animal health and welfare, biosecurity, and the judicious use of antibiotics in veterinary medicine to combat the threat of antibiotic resistance.

This article is a stub. You can help WikiMD by registering to expand it. Editing is available only to registered and verified users. WikiMD is a comprehensive, free health & wellness encyclopedia.